Add to ORKGThe opioid receptor agonist remifentanil (REM) has been shown to attenuate myocardial ischemia reperfusion injury, but the underlying mechanism is unclear. We hypothesized that REM confers cardioprotection by activating the ...link_to_OA_fulltextThe Experiment Biology Meeting (EB 2011), Washington, D.C., 9-13 April 2011. In The FASEB Journal, 2011, v. 25 Meeting abstract suppl., abstract no. 1085.
Many factors present during the perioperative period render patients susceptible in developing myoca...
BACKGROUND: Hyperglycemia attenuates cardioprotection by remifentanil-preconditioning in ischemia-re...
Remifentanil, an ultra-short acting opiate, has been reported to protect against hepatic ischemia-re...
Background: Remifentanil preconditioning (RPC) reduces the infarct size in anesthetized rat hearts, ...
Background. Preconditioning with remifentanil (RPC) provides immediate cardioprotection in rats via ...
Remifentanil is an ultra-short-acting phenylpiperidine opioid analgesic that is rapidly metabolized ...
Remifentanil is a commonly used opioid in anesthesia with cardioprotective effect in ischemia-reperf...
Diabetes mellitus has been known to mitigate ischemic or pharmacologic preconditioning in ischemia-r...
This journal suppl. contain Abstracts of Posters presented at the 2011 Annual Meeting of the Interna...
Topic: Experimental Circulation: abstract no. A1486INTRODUCTION: Remifentanil preconditioning (RPC) ...
BACKGROUND: Opioid preconditioning against ischemia reperfusion injury has been well studied in myoc...
Dept. of Medicine/박사Remifentanil has been reported to havecardioprotective effects against the ische...
Remifentanil post-conditioning attenuates cardiac ischemia–reperfusion injury via j or d opioid rece...
BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract ...
Background: Ischemic pre- or post-conditioning of the heart has been shown to involve opioid recepto...
Many factors present during the perioperative period render patients susceptible in developing myoca...
BACKGROUND: Hyperglycemia attenuates cardioprotection by remifentanil-preconditioning in ischemia-re...
Remifentanil, an ultra-short acting opiate, has been reported to protect against hepatic ischemia-re...
Background: Remifentanil preconditioning (RPC) reduces the infarct size in anesthetized rat hearts, ...
Background. Preconditioning with remifentanil (RPC) provides immediate cardioprotection in rats via ...
Remifentanil is an ultra-short-acting phenylpiperidine opioid analgesic that is rapidly metabolized ...
Remifentanil is a commonly used opioid in anesthesia with cardioprotective effect in ischemia-reperf...
Diabetes mellitus has been known to mitigate ischemic or pharmacologic preconditioning in ischemia-r...
This journal suppl. contain Abstracts of Posters presented at the 2011 Annual Meeting of the Interna...
Topic: Experimental Circulation: abstract no. A1486INTRODUCTION: Remifentanil preconditioning (RPC) ...
BACKGROUND: Opioid preconditioning against ischemia reperfusion injury has been well studied in myoc...
Dept. of Medicine/박사Remifentanil has been reported to havecardioprotective effects against the ische...
Remifentanil post-conditioning attenuates cardiac ischemia–reperfusion injury via j or d opioid rece...
BACKGROUND AND OBJECTIVES: Serious functional and structural alterations of gastrointestinal tract ...
Background: Ischemic pre- or post-conditioning of the heart has been shown to involve opioid recepto...
Many factors present during the perioperative period render patients susceptible in developing myoca...
BACKGROUND: Hyperglycemia attenuates cardioprotection by remifentanil-preconditioning in ischemia-re...
Remifentanil, an ultra-short acting opiate, has been reported to protect against hepatic ischemia-re...